Drug Research
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the United States upon approval. Rimegepant is commercialized as Nurtec® ODT in the U.S., and is indicated for the acute...
Press Releases
Brooks Automation Announces New Agreement With QTC Management to Support The Military Reserve Health Readiness Program
Brooks Automation, Inc. announced that its newly branded Azenta Life Sciences business has been contracted by QTC Management, Inc., a Leidos company , to provide the storage and distribution of vaccines to the U.S. Department of Defense.
Earlier this year,...
Press Releases
PCI Pharma Services Announces First-of-Its-Kind Clinical Supply Center of Excellence in Boston Area
PCI Pharma Services is pleased to announce the construction of a new Clinical Center of Excellence in Bridgewater, Massachusetts providing clinical storage, distribution and packaging to meet the growing New England clinical supply market demands.
We are the first global...
Drug Research
Phillips-Medisize and Exact Sciences Collaborate to Fight Colorectal Cancer
Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, announces the successful collaboration with Exact Sciences, a global leader in cancer diagnostics, to advance early cancer detection. Fueled by a relentless pursuit for smarter, earlier...
Drug Research
Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery
Standigm Inc., the leading workflow artificial intelligence (AI) drug discovery company, announced that the company had established a Synthetic Research Center in the headquarters of SK Chemicals Co., Ltd, a life science and green chemicals company.
Standigm has dramatically improved...
Drug Research
IFF Displays Innovative Pharmaceutical Solutions, Tailored to Address Current, Future Industry Challenges
As the pharmaceutical industry continues to evolve – introducing increasingly complex drugs, unique applications and new dosage forms – the Pharma Solutions division of IFF is dedicated to helping formulators and manufacturers evolve alongside it. Armed with extensive expertise...
Drug Research
Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation gene editing tools, announced that the two companies have entered into a strategic research...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.